I can't share the link because of my posting restriction, but the article is on CNN.
Eli Lilly makes Orforglipron, which carries the brand name Foundayo. Under the arrangement, Medicare would cover the pill for certain patients too, at a monthly cost below $50, beginning as early as July 1.
In 1 trial that backed the approval, participants taking Foundayo at the highest dose dropped an average of 12% of their body weight across 72 weeks, versus 0.9% among those on a placebo. Injectable versions have achieved more than 20% weight loss in trials, and Novo Nordisk reported that its Wegovy pill reached average weight loss of up to 17% at the highest dose in trials.
These pills also mark a big shift in GLP-1 pricing and access; through a deal reached with the administration in November, for patients paying out of pocket the pills begin at $149 a month at the lowest doses, far less than what had been available before.
----
Speaking only for myself and without expertise, a pill format could make manufacturing and distribution simpler and cheaper. It might also smooth out the spikes that come with weekly Zepbound injections. That would be valuable as a maintenance option once millions of people have finished their major weight loss and only need a modest assist to hold the weight off.
Eli Lilly makes Orforglipron, which carries the brand name Foundayo. Under the arrangement, Medicare would cover the pill for certain patients too, at a monthly cost below $50, beginning as early as July 1.
In 1 trial that backed the approval, participants taking Foundayo at the highest dose dropped an average of 12% of their body weight across 72 weeks, versus 0.9% among those on a placebo. Injectable versions have achieved more than 20% weight loss in trials, and Novo Nordisk reported that its Wegovy pill reached average weight loss of up to 17% at the highest dose in trials.
These pills also mark a big shift in GLP-1 pricing and access; through a deal reached with the administration in November, for patients paying out of pocket the pills begin at $149 a month at the lowest doses, far less than what had been available before.
----
Speaking only for myself and without expertise, a pill format could make manufacturing and distribution simpler and cheaper. It might also smooth out the spikes that come with weekly Zepbound injections. That would be valuable as a maintenance option once millions of people have finished their major weight loss and only need a modest assist to hold the weight off.
